TUBERCULOSIS WITH MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT OF MICOBACTERIUM TUBERCULOSIS IN THE RUSSIAN FEDERATION

Objective: To assess the epidemic situation in the Russian Federation on tuberculosis with multidrug-resistant and extensively drug-resistant (MDR, XDR) of the pathogen and the effectiveness of its treatment. Methods: The information on forms of official statistical observation of the Russian Fed...

Full description

Bibliographic Details
Main Authors: A.E. ERGESHOV, V.V. PUNGA, L.I. RUSAKOVA, S.A. STERLIKOV, M.A. YAKIMOVA, Т.V. IZMAYLOVA
Format: Article
Language:English
Published: Avicenna Tajik State Medical University 2018-08-01
Series:Паёми Сино
Subjects:
Online Access:https://doi.org/10.25005/2074-0581-2018-20-2-3-314-319
_version_ 1797797263315042304
author A.E. ERGESHOV
V.V. PUNGA
L.I. RUSAKOVA
S.A. STERLIKOV
M.A. YAKIMOVA
Т.V. IZMAYLOVA
author_facet A.E. ERGESHOV
V.V. PUNGA
L.I. RUSAKOVA
S.A. STERLIKOV
M.A. YAKIMOVA
Т.V. IZMAYLOVA
author_sort A.E. ERGESHOV
collection DOAJ
description Objective: To assess the epidemic situation in the Russian Federation on tuberculosis with multidrug-resistant and extensively drug-resistant (MDR, XDR) of the pathogen and the effectiveness of its treatment. Methods: The information on forms of official statistical observation of the Russian Federation for 2009-2017 was studied. The calculated indicators describing the reservoir of tuberculosis with MDR and XDR of the pathogen are calculated and analyzed the results of treatment. Results: In 2009-2017 in the civil healthcare, the proportion of tuberculosis patients tested for drug sensitivity increased from 70.9% to 92.6%. The share of tuberculosis patients with MDR increased from 37.3% to 58.4%. The number of patients and prevalence of tuberculosis with MDR stabilized at the level of 24.2-25.9 per 100 thousand of the population. Primary MDR increased from 16.0% to 28.2%. The share of tuberculosis cases with XDR among cases of tuberculosis with MDR is from 11% to 13%. The number of registered cases of tuberculosis with established or presumed resistance, at least to rifampicin, increased from 15,896 in 2011 to 24,367 in 2015, and the frequency of their successful treatment increased from 37.1% to 53.5%. The number of cases registered for treatment of tuberculosis with XDR has increased from 1318 in 2012 to 2614 in 2015, and the frequency of successful treatment has increased from 26.1% to 34.2%. In 2009-2017 an increase in the rate of abacillation of patients with tuberculosis with MDR from 12.9 to 26.2 per 100 average annual bacterial excreta. Conclusion: In the Russian Federation, there is a stabilization of the epidemic situation in tuberculosis with MDR, but the process of replacing sensitive strains of the pathogen with drug-resistant strains continues. The indicator of the frequency of detection of cases of tuberculosis with MDR of the pathogen in the Russian Federation is 91.5% in relation to the data of WHO experts. The increase in the proportion of successful treatment of patients with MDR and XDR tuberculosis is associated with providing patients with access to anti-tuberculosis drugs of the reserve series, improving the clinical management of patients, introducing new anti-tuberculosis drugs and treatment protocols, and improving the patient's motivation for treatment.
first_indexed 2024-03-13T03:45:31Z
format Article
id doaj.art-5d3aae968a264970a8303d880eb90966
institution Directory Open Access Journal
issn 2074-0581
2959-6327
language English
last_indexed 2024-03-13T03:45:31Z
publishDate 2018-08-01
publisher Avicenna Tajik State Medical University
record_format Article
series Паёми Сино
spelling doaj.art-5d3aae968a264970a8303d880eb909662023-06-22T21:48:49ZengAvicenna Tajik State Medical UniversityПаёми Сино2074-05812959-63272018-08-01202-331431910.25005/2074-0581-2018-20-2-3-314-319TUBERCULOSIS WITH MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT OF MICOBACTERIUM TUBERCULOSIS IN THE RUSSIAN FEDERATIONA.E. ERGESHOV0V.V. PUNGA1L.I. RUSAKOVA2S.A. STERLIKOV3M.A. YAKIMOVA4Т.V. IZMAYLOVA5Central Tuberculosis Research Institute, Moscow, Russian FederationCentral Tuberculosis Research Institute, Moscow, Russian FederationCentral Tuberculosis Research Institute, Moscow, Russian FederationCentral Tuberculosis Research Institute, Moscow, Russian Federation. Federal Research Institute for Health Organization and Informatics, Moscow, Russian FederationCentral Tuberculosis Research Institute, Moscow, Russian FederationCentral Tuberculosis Research Institute, Moscow, Russian FederationObjective: To assess the epidemic situation in the Russian Federation on tuberculosis with multidrug-resistant and extensively drug-resistant (MDR, XDR) of the pathogen and the effectiveness of its treatment. Methods: The information on forms of official statistical observation of the Russian Federation for 2009-2017 was studied. The calculated indicators describing the reservoir of tuberculosis with MDR and XDR of the pathogen are calculated and analyzed the results of treatment. Results: In 2009-2017 in the civil healthcare, the proportion of tuberculosis patients tested for drug sensitivity increased from 70.9% to 92.6%. The share of tuberculosis patients with MDR increased from 37.3% to 58.4%. The number of patients and prevalence of tuberculosis with MDR stabilized at the level of 24.2-25.9 per 100 thousand of the population. Primary MDR increased from 16.0% to 28.2%. The share of tuberculosis cases with XDR among cases of tuberculosis with MDR is from 11% to 13%. The number of registered cases of tuberculosis with established or presumed resistance, at least to rifampicin, increased from 15,896 in 2011 to 24,367 in 2015, and the frequency of their successful treatment increased from 37.1% to 53.5%. The number of cases registered for treatment of tuberculosis with XDR has increased from 1318 in 2012 to 2614 in 2015, and the frequency of successful treatment has increased from 26.1% to 34.2%. In 2009-2017 an increase in the rate of abacillation of patients with tuberculosis with MDR from 12.9 to 26.2 per 100 average annual bacterial excreta. Conclusion: In the Russian Federation, there is a stabilization of the epidemic situation in tuberculosis with MDR, but the process of replacing sensitive strains of the pathogen with drug-resistant strains continues. The indicator of the frequency of detection of cases of tuberculosis with MDR of the pathogen in the Russian Federation is 91.5% in relation to the data of WHO experts. The increase in the proportion of successful treatment of patients with MDR and XDR tuberculosis is associated with providing patients with access to anti-tuberculosis drugs of the reserve series, improving the clinical management of patients, introducing new anti-tuberculosis drugs and treatment protocols, and improving the patient's motivation for treatment.https://doi.org/10.25005/2074-0581-2018-20-2-3-314-319tuberculosismultiple drug resistanceextensively drug resistancetreatment outcomes.
spellingShingle A.E. ERGESHOV
V.V. PUNGA
L.I. RUSAKOVA
S.A. STERLIKOV
M.A. YAKIMOVA
Т.V. IZMAYLOVA
TUBERCULOSIS WITH MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT OF MICOBACTERIUM TUBERCULOSIS IN THE RUSSIAN FEDERATION
Паёми Сино
tuberculosis
multiple drug resistance
extensively drug resistance
treatment outcomes.
title TUBERCULOSIS WITH MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT OF MICOBACTERIUM TUBERCULOSIS IN THE RUSSIAN FEDERATION
title_full TUBERCULOSIS WITH MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT OF MICOBACTERIUM TUBERCULOSIS IN THE RUSSIAN FEDERATION
title_fullStr TUBERCULOSIS WITH MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT OF MICOBACTERIUM TUBERCULOSIS IN THE RUSSIAN FEDERATION
title_full_unstemmed TUBERCULOSIS WITH MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT OF MICOBACTERIUM TUBERCULOSIS IN THE RUSSIAN FEDERATION
title_short TUBERCULOSIS WITH MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT OF MICOBACTERIUM TUBERCULOSIS IN THE RUSSIAN FEDERATION
title_sort tuberculosis with multidrug resistant and extensively drug resistant of micobacterium tuberculosis in the russian federation
topic tuberculosis
multiple drug resistance
extensively drug resistance
treatment outcomes.
url https://doi.org/10.25005/2074-0581-2018-20-2-3-314-319
work_keys_str_mv AT aeergeshov tuberculosiswithmultidrugresistantandextensivelydrugresistantofmicobacteriumtuberculosisintherussianfederation
AT vvpunga tuberculosiswithmultidrugresistantandextensivelydrugresistantofmicobacteriumtuberculosisintherussianfederation
AT lirusakova tuberculosiswithmultidrugresistantandextensivelydrugresistantofmicobacteriumtuberculosisintherussianfederation
AT sasterlikov tuberculosiswithmultidrugresistantandextensivelydrugresistantofmicobacteriumtuberculosisintherussianfederation
AT mayakimova tuberculosiswithmultidrugresistantandextensivelydrugresistantofmicobacteriumtuberculosisintherussianfederation
AT tvizmaylova tuberculosiswithmultidrugresistantandextensivelydrugresistantofmicobacteriumtuberculosisintherussianfederation